Pan L, Mu L, Lei H, Miao S, Hu X, Tang Z
Int J Clin Pharm. 2024; .
PMID: 39470981
DOI: 10.1007/s11096-024-01818-7.
Mestrallet G
Cancers (Basel). 2024; 16(2).
PMID: 38254897
PMC: 10813889.
DOI: 10.3390/cancers16020408.
Jia K, Wang Y, Cao Q, Wang Y
Oncol Res. 2024; 32(2):409-419.
PMID: 38186568
PMC: 10765129.
DOI: 10.32604/or.2023.042863.
Kim W, Cho Y, Min K, Kim D, Lee K
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631013
PMC: 10457804.
DOI: 10.3390/ph16081097.
Borchert S, Mathilakathu A, Nath A, Wessolly M, Mairinger E, Kreidt D
Int J Mol Sci. 2023; 24(15).
PMID: 37569808
PMC: 10419996.
DOI: 10.3390/ijms241512426.
Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment.
Li M, Jiang P, Wei S, Yang Y, Xiong L, Wang J
Biomolecules. 2023; 13(6).
PMID: 37371484
PMC: 10295969.
DOI: 10.3390/biom13060904.
Artificial intelligence-based non-small cell lung cancer transcriptome RNA-sequence analysis technology selection guide.
Joo M, Pyo K, Chung J, Cho B
Front Bioeng Biotechnol. 2023; 11:1081950.
PMID: 36873350
PMC: 9975749.
DOI: 10.3389/fbioe.2023.1081950.
Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review.
Li J, Wu J, Zhao Z, Zhang Q, Shao J, Wang C
J Thorac Dis. 2022; 13(12):7021-7033.
PMID: 35070384
PMC: 8743400.
DOI: 10.21037/jtd-21-864.
A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy.
Xu B, Lu M, Yan L, Ge M, Ren Y, Wang R
Front Immunol. 2021; 12:796647.
PMID: 34956232
PMC: 8695566.
DOI: 10.3389/fimmu.2021.796647.
Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data.
Benzekry S, Grangeon M, Karlsen M, Alexa M, Bicalho-Frazeto I, Chaleat S
Cancers (Basel). 2021; 13(24).
PMID: 34944830
PMC: 8699503.
DOI: 10.3390/cancers13246210.
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions.
Lawlor R, Mattiolo P, Mafficini A, Hong S, Piredda M, Taormina S
Cancers (Basel). 2021; 13(13).
PMID: 34206554
PMC: 8269341.
DOI: 10.3390/cancers13133119.
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers.
Tolba M, Elghazaly H, Bousoik E, Elmazar M, Tolaney S
Clin Transl Oncol. 2021; 23(10):1979-1994.
PMID: 33871826
DOI: 10.1007/s12094-021-02613-w.
Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer.
Hildebrand L, Pierce C, Dennis M, Paracha M, Maoz A
Cancers (Basel). 2021; 13(3).
PMID: 33494280
PMC: 7864494.
DOI: 10.3390/cancers13030391.
Tumor microenvironment as a therapeutic target in cancer.
Xiao Y, Yu D
Pharmacol Ther. 2020; 221:107753.
PMID: 33259885
PMC: 8084948.
DOI: 10.1016/j.pharmthera.2020.107753.
Machine and deep learning approaches for cancer drug repurposing.
Issa N, Stathias V, Schurer S, Dakshanamurthy S
Semin Cancer Biol. 2020; 68:132-142.
PMID: 31904426
PMC: 7723306.
DOI: 10.1016/j.semcancer.2019.12.011.
Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?.
Zhang X, He Y, Jia K, Dziadziuszko R, Zhao S, Deng J
Transl Lung Cancer Res. 2019; 8(5):559-574.
PMID: 31737493
PMC: 6835112.
DOI: 10.21037/tlcr.2019.09.20.
